June 22, 2020 / 9:05 AM / 13 days ago

BRIEF-Betta Pharmaceuticals Agrees To Obtain Commercialization Rights For Agenus' Drugs

June 22 (Reuters) - Betta Pharmaceuticals Co Ltd :

* SAYS IT AGREES TO OBTAIN COMMERCIALIZATION RIGHTS FOR AGENUS’ BALSTILIMAB AND ZALIFRELIMAB IN MAINLAND CHINA, HONG KONG, MACAU AND TAIWAN

* SAYS THE RIGHTS EXCLUDE DRUG USE VIA INTRAVESICAL ADMINISTRATION

* SAYS ITS HONG KONG UNIT AGREES TO BUY 4.96 MILLION SHARES IN AGENUS FOR $20 MILLION Source text in Chinese: bit.ly/2V8IyNj Further company coverage: (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below